文献速递心脑血管急症重症综合管理与镇静镇痛

癫痫样活动与中毒代谢性脑病结局的相关性

Association of Epileptiform Activity With Outcomes in Toxic-Metabolic Encephalopathy.
PubMed 文献 · Crit Care Explor · 2023-05-05
一句话结论中毒代谢性脑病患者cEEG出现癫痫样活动与出院时不良神经结局相关(OR 3.89),癫痫样活动负荷从0%增至100%可使不良结局概率增加30%。

这项回顾性研究纳入2012至2019年单中心连续收治、接受cEEG监测的中毒代谢性脑病(TME)成人患者,将58例伴癫痫样异常(EA)者与58例按年龄及APACHE-II评分匹配的无EA对照比较。总体出院死亡率22%,70%出院时神经结局不良(mRS 4-6)。校正Charlson共病指数与原发诊断后,EA存在与不良结局相关(OR 3.89,95%CI 1.05-14.2,P=0.041);峰值EA负荷从0%升至100%使不良出院神经结局概率增加30%。作者认为EA负荷增加与TME患者出院结局更差相关,未来需研究在治疗基础代谢紊乱的同时短期使用抗癫痫药物能否改善结局。

要点

  • TME患者cEEG出现EA与出院不良神经结局(mRS 4-6)独立相关:OR 3.89(95%CI 1.05-14.2,P=0.041)。
  • 峰值EA负荷从0%升至100%,出院不良神经结局概率增加30%。
  • 研究队列总体出院死亡率22%,70%出院时mRS 4-6。
  • 匹配后EA组与对照组各58例,中位年龄66岁(Q1-Q3 57-75),中位APACHE-II 18分(Q1-Q3 13-22)。
  • 作者认为需进一步研究在治疗基础代谢紊乱的同时短期使用抗癫痫药物能否改善结局。

适用人群与场景

  • 2012至2019年单中心连续收治于住院病房或ICU并接受cEEG监测的成人患者。
  • 纳入标准:TME诊断、年龄大于18岁、cEEG监测时间大于或等于16小时。
  • 排除急性脑损伤和心脏骤停患者。

诊断标准与关键阈值

  • 不良神经结局定义为出院时改良Rankin量表(mRS)4-6分。
  • 峰值EA负荷定义为记录中EA最普遍的12小时窗口。

研究设计与关键结果

  • 研究类型:回顾性研究;58例TME伴EA患者与58例按年龄、SOFA评分、APACHE-II评分匹配的无EA对照,匹配在年龄和APACHE-II评分上进行;单中心。
  • 中位年龄66岁(Q1-Q3 57-75),中位APACHE-II评分18分(Q1-Q3 13-22);总体出院死亡率22%,70%出院时神经结局不良。
  • 校正Charlson共病指数和原发诊断的多变量分析中,EA存在与不良结局相关:OR 3.89(95%CI 1.05-14.2),P=0.041。
  • 峰值EA负荷从0%增至100%,出院不良神经结局概率增加30%。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,TME患者EA负荷增加与出院结局更差相关。
  • 作者认为,未来需研究在药物治疗基础代谢紊乱的同时短期使用抗癫痫药物能否改善结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: The clinical significance of epileptiform abnormalities (EAs) specific to toxic-metabolic encephalopathy (TME) is unknown.

OBJECTIVES: To quantify EA burden in patients with TME and its association with neurologic outcomes.

DESIGN SETTING AND PARTICIPANT: This is a retrospective study. A cohort of patients with TME and EA (positive) were age, Sequential Organ Failure Assessment Score, Acute Physiology and Chronic Health Evaluation II (APACHE-II) score matched to a cohort of TME patients without EA (control). Univariate analysis compared EA-positive patients against controls. Multivariable logistical regression adjusting for underlying disease etiology was performed to examine the relationship between EA burden and probability of poor neurologic outcome (modified Rankin Score [mRS] 4-6) at discharge. Consecutive admissions to inpatient floors or ICUs that underwent continuous electroencephalography (cEEG) monitoring at a single center between 2012 and 2019. Inclusion criteria were 1) patients with TME diagnosis, 2) age greater than 18 years, and 3) greater than or equal to 16 hours of cEEG. Patients with acute brain injury and cardiac arrest were excluded.

MAIN OUTCOMES AND MEASURES: Poor neurologic outcome defined by mRS (mRS 4-6).

RESULTS: One hundred sixteen patients were included, 58 with EA and 58 controls without EA, where matching was performed on age and APACHE-II score. The median age was 66 (Q1-Q3, 57-75) and median APACHE II score was 18 (Q1-Q3, 13-22). Overall cohort discharge mortality was 22% and 70% had a poor neurologic outcome. Peak EA burden was defined as the 12-hour window of recording with the highest prevalence of EAs. In multivariable analysis adjusted for Charlson Comorbidity Index and primary diagnosis, presence of EAs was associated with poor outcome (odds ratio 3.89; CI [1.05-14.2], p = 0.041). Increase in peak EA burden from 0% to 100% increased probability of poor discharge neurologic outcome by 30%.

CONCLUSIONS AND RELEVANCE: Increasing burden of EA is associated with worse discharge outcomes in patients with TME. Future studies are needed to determine whether short-term treatment with anti-seizure medications while medically treating the underlying metabolic derangement improves outcomes.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Chen PM, Stekhoven SS, Haider A, et al. Association of Epileptiform Activity With Outcomes in Toxic-Metabolic Encephalopathy. Crit Care Explor. 2023. PMID: 37168691. doi:10.1097/CCE.0000000000000913

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。